SOURCE: PHT Corporation

May 19, 2008 09:12 ET

PHT Corporation to Outline Benefits of ePRO at 2nd CBI Forum on Patient Reported Outcomes (PRO)

Barbara Marino, PhD, RN to Offer Perspective on Safety, Cost and Efficacy Benefits of Adopting Electronic Data Capture (EDC)

BOSTON, MA--(Marketwire - May 19, 2008) - Tomorrow at the CBI 2nd Annual Forum on Patient Reported Outcomes (PRO), PHT's Barbara Marino, PhD, RN, Director of Clinical Operations and Scientific Advisor, will join industry experts to discuss the move from unreliable paper methods to proven electronic technologies in clinical research. PHT is the market-leading provider of ePRO solutions used in more than 350 clinical trials worldwide.

Jeff Sloan, PhD, Lead Statistician at the Mayo Clinic, will moderate what promises to be a lively session titled, "The Great Debate -- Paper Versus ePRO." Dr. Marino will share PHT's experience in hundreds of complex, multi-language, multi-national ePRO trials with industry experts Robert Baran, Senior Manager, Health Economics and Outcomes Research at Takeda and Deborah P. Lubeck, Ph.D., Vice President, Scientific Affairs at Icon.

After the publication of the FDA's PRO Draft Guidance, researchers at the Mayo Clinic worked with FDA personnel and experts from academia, industry, clinical research and clinical practices to facilitate discussion, dissemination and operationalization of the document.

Derived from this collective effort is a manuscript series that analyzes the major components of the FDA guidance (Value in Health 2007). Using the manuscript series as a guide, industry thought leaders will convene to share their experiences and unique knowledge of PRO.

The conference takes place May 21-22, in Philadelphia. For more information, visit www.cbinet.com.

About PHT Corporation

Trust your patient and questionnaire data again. PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 350 clinical trials by 90 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient, in 80 languages, from homes and sites in 60 countries around the world. By capturing high-quality and time stamped assessments with minimal respondent burden, transmitted over reliable analog and wireless global technologies, sponsors are able to run smaller and more conclusive clinical research programs. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry's premier study archive. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least seven known NDA approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad, SitePad, StudyWorks and SafetyPRO are among the registered trademarks and trademarks of PHT Corporation.

Contact Information